Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

ResearchMoz.us includes new market research report " Therapeutic Antibodies Market 2015 - Biosimilars & Biosuperiors: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

This Competitive Intelligence Report about Therapeutic Antibodies 2015: Biosimilars & Biosuperiors provides a competitor evaluation in the field of recombinant monoclonal and polyclonal antibodies in the market, in the pipeline as next generation products and as biosimilar versions as of April 2015.

View report details with TOC at: http://www.researchmoz.us/competitor-analysis-therapeutic-antibodies-2015-biosimilars-and-biosuperiors-report.html

Total sales of recombinant therapeutic monoclonal antibodies originating from companies located in regulated markets reached US$ 82.2 bln (+8.6% vs previous year) in the year 2014.

The report lists specifically for each target the branded products with their 2014 sales and up-side indications in development, as well as biosuperior and biosimilar antibody drug candidates in development.

The report includes a compilation of currently active projects in research and development of biosimilar and biosuperior therapeutic antibodies against commercially and clinically validated targets:

VEGF

TNF

Her2

CD20

EGF-R

B7.1/B7.2 (CD80/CD86)

IL-6R

Alpha4/beta1/7 integrin

IgE

RSV

RANKL

Complement C5

IL-12/IL-23

CD52

Request a FREE copy of a SMAPLE REPORT at: http://www.researchmoz.com/enquiry.php?type=sample&repid=258450

Competitor projects are listed in a tabular format providing information on:

Drug Codes,

Target / Mechanism of Action,

Class of Compound,

Company,

Product Category,

Indication,

R&D Stage and

additional comments with a hyperlink leading to the source of information.

Browse More reports related to Therapeutic Industry at: http://www.researchmoz.us/therapeutic-area-market-reports-37.html

About Us:

ResearchMoz ( http://www.researchmoz.us/ ) is the one...